NCT01820091 2020-01-23Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®Acrotech Biopharma Inc.Phase 1 Withdrawn